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Background: Bacterial colonization and recurrent infections of the respiratory tract contribute to the progression of
chronic obstructive pulmonary disease (COPD). There is evidence that exacerbations of COPD are provoked by new
bacterial strains acquired from the environment. Using a murine model of colonization, we examined whether
chronic exposure to cigarette smoke (CS) promotes nasopharyngeal colonization with typical lung pathogens and
whether colonization is linked to inflammation in the respiratory tract.
Methods: C57BL/6 N mice were chronically exposed to CS. The upper airways of mice were colonized with
nontypeable Haemophilus influenzae (NTHi) or Streptococcus pneumoniae. Bacterial colonization was determined in
the upper respiratory tract and lung tissue. Inflammatory cells and cytokines were determined in lavage fluids.
RT-PCR was performed for inflammatory mediators.
Results: Chronic CS exposure resulted in significantly increased numbers of viable NTHi in the upper airways,
whereas NTHi only marginally colonized air-exposed mice. Colonization with S. pneumoniae was enhanced in the
upper respiratory tract of CS-exposed mice and was accompanied by increased translocation of S. pneumoniae into
the lung. Bacterial colonization levels were associated with increased concentrations of inflammatory mediators and
the number of immune cells in lavage fluids of the upper respiratory tract and the lung. Phagocytosis activity was
reduced in whole blood granulocytes and monocytes of CS-exposed mice.
Conclusions: These findings demonstrate that exposure to CS impacts the ability of the host to control bacterial
colonization of the upper airways, resulting in enhanced inflammation and susceptibility of the host to pathogens
migrating into the lung.
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Respiratory diseases associated with cigarette smoke
(CS) are a leading cause of morbidity and mortality
worldwide. The most prominent respiratory disease
caused by CS is chronic obstructive pulmonary disease
(COPD) and it is most likely that it will constitute the
fourth most common cause of death by the year 2030
[1]. A hallmark of COPD is chronic inflammation of the* Correspondence: christoph.beisswenger@uks.eu
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unless otherwise stated.lung, leading to tissue destruction. The ongoing tissue
destruction leads to emphysema and loss of pulmonary
function [2,3].
Stable COPD patients are frequently colonized by bac-
terial pathogens, such as nontypeable H. influaenzae,
Pseudomonas aeruginosa, and S. pneumoniae [2,4,5].
Moreover, recurrent infections of the respiratory tract
and chronic bronchitis are common in COPD [2-5]. It is
suggested that acute bacterial lung infections as well as
chronic bacterial colonization of the lung contribute to
the progression of COPD by amplifying inflammation
which further promotes lung damage and impacts innate
lung defence [2]. In addition, pathogenic bacteria causeis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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thereby contribute to impaired mucociliary clearance,
elevated mucus secretion and subsequent mucus reten-
tion, disrupted ciliary activity, and finally airflow ob-
struction [3,6,7].
There is evidence that exacerbations are provoked by
the acquisition of new bacterial strains from the environ-
ment by the host [2,3]. It is hypothesized that newly-
acquired bacterial pathogens trigger infections of the
lung and evoke harmful inflammatory responses, con-
tributing to clinical deterioration of the patient during
exacerbation [2,3,8]. Among the most frequent bac-
terial pathogens isolated from patients suffering from
exacerbation are H. influenzae (20–30% of patients)
and S. pneumoniae (10–15% of patients) [2].
Several studies have shown that CS has an impact on
the immune system of the respiratory tract, even in
healthy individuals [9,10]. Thus, smoking and passive
smoking are associated with disordered microbial com-
munities of the upper airways, impairment of com-
mensal airway flora, and an increased risk of bacterial
infections in healthy individuals [4,11-14]. Brook and
Goober demonstrated that the nasopharyngeal flora of
smokers contains fewer aerobic and anaerobic organisms
with interfering capabilities and more potential patho-
gens, such as H. influenzae and S. pneumoniae, com-
pared with those of non-smokers [12]. It is also
suggested that smoking enhances colonization of the
oral cavity with periodontal pathogens, affects the sub-
gingival microflora in periodontitis, and is a risk factor
for periodontal disease [15,16]. Moreover, cigarette
smoking increases the risk of community-acquired pneu-
monia [17,18] and is a strong independent risk factor for
invasive pneumococcal disease among immunocompe-
tent, non-elderly adults [19]. Exposure to passive smoke
favors bacterial colonization and infection in infants
[12-14,20]. Greenberg et al. reported that children of
smoking parents have a significantly higher rate of
S. pneumoniae carriage than children of non-smokers
[14]. Exposure to passive smoke also correlates with
a significantly increased risk of infants developing in-
fections of the lower respiratory tract in the first two
years of life [20].
It was the aim of the present study to investigate
whether chronic exposure to CS promotes nasopharyn-
geal colonization with the leading gram-positive and
gram-negative bacterial lung pathogens H. influenzae
and S. pneumoniae by combining a clinically relevant
murine model of colonization of the upper respira-
tory tract with a model of chronic CS exposure [21].
It was further investigated whether CS-promoted
colonization of the upper-respiratory tract results in
increased inflammation and bacterial translocation
into the lung.Methods
Bacterial strains and products
A patient isolate of H. influenzae (ATCC® 49247™) was
grown overnight at 37°C and 5% CO2 on chocolate agar
(Becton Dickinson, Germany). Bacteria were taken from
the plate and re-suspended in 7 ml 1 × PBS to obtain an
optical density of 1 at 600 nm. Bacteria were spun at
4000 rpm and 4°C for 10 minutes and re-suspended in
350 μl 1 × PBS for the infection. A type 6A clinical iso-
late of S. pneumoniae (a gift from Dr. Jeffrey Weiser,
University of Pennsylvania) [22,23] was cultured in Todd
Hewitt broth at 37°C. Mid-log-phase S. pneumoniae
were washed with PBS and re-suspenended in 450 μl
1 × PBS.
CS exposure and nasopharyngeal colonization
All animal experiments were approved by the Landesamt
für Soziales, Gesundheit und Verbraucherschutz of the
State of Saarland following the national guidelines for
animal treatment. Mice were maintained under a
pathogen-free condition. 7 to 9 week-old female wild-
type C57BL/6 N mice were exposed to a combination
of sidestream and mainstream CS (3R4F, College of
Agriculture, Reference Cigarette Program, University of
Kentucky, Lexington, Kentucky, USA) in a TE-10 smok-
ing machine (Teague Enterprises, Woodland, California,
USA) for a total of 261 minutes/day, 5 days per week.
The smoking time was 87 minutes with 40 minutes
air exposure in between CS exposures, with 3 CS
exposures/day. Mice were exposed to CS or air for
13 (3 months) or 30 weeks (7 months) as indicated
in the figures. The CS concentration was 120 mg/m3
total suspended particles. 24 hours after the final CS
exposure the upper airways of room air- and CS-exposed
mice were colonized using an established model of naso-
pharyngeal colonization [22-24]. Mice were inoculated
intranasally with 10 μl of mid-log phase NTHi (5.5 × 106
to 4.5 × 107 CFU) or S. pneumoniae 6A (1.5 × 107 to
2.5 × 107 CFU) applied atraumatically to the nares with-
out anesthesia.
Lavage of the upper airways and bronchoalveolar lavage
and phagocytosis
Lavage of the upper airways and bronchoalveolar lavage
(BAL) were performed as described before [22,23].
Briefly, the animals were sacrificed and the trachea were
cannulated. Lavage of the upper airways was performed
with 300 μl of PBS. To obtain BAL fluids from the lung
BAL was performed with 1 ml of PBS flushed three
times into the lungs. Lavage fluids were plated in serial
dilutions and CFUs were determined. Lavage fluids were
centrifuged to obtain immune cells and supernatants.
Cell numbers were determined. Inflammatory cells were
differentiated on cytospins. Serum was obtained by
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monocytes and granulocytes obtained from mice ex-
posed to air or CS for 3 months was determined using a
flow cytometry-based assays (Phagotest, Orpegen Pharma,
Germany), according to the instruction. Samples were
analyzed in a FACS Calibur flow cytometer (Beckton
Dickinson, Heidelberg, Germany). Gates (forward/side
scatter) were set on granulocytes and monocytes. For de-
termination of the phagocytosis activity in each sample the
mean fluorescence intensity was calculated according to
the instruction of the manufacturer (MFI).
Determination of cytokine concentrations and
immunohistochemistry
Concentrations of inflammatory mediators were assessed
by cytometric bead array (CBA) using a FACSCanto II
(BD Bioscience, Germany). For immunohistochemistry
of the upper respiratory tract, the heads of the mice
were fixed in 4%-PBS-buffered formaldehyde and decal-
cified [22]. Immunohistochemistry on paraffin sections
was performed as described before, using anti-H. influ-
enzae (abcam, USA) antibody [25,26].Figure 1 Colonization levels in the upper airways of mice inoculated
intranasally inoculated with NTHi. Colonization densities were determined b
postinoculation. Data are shown as mean ± SEM. Bars indicate significant d
tissue by immunohistochemistry (red staining). Scale bar, 100 μm.Quantitative real-time PCR
Total RNA from the upper airways was isolated after
flushing the upper airways to obtain cells [23]. The
upper airways were flushed with 300 μl RLT Lysis buffer
(Qiagen, Germany). RNA was isolated and reverse tran-
scription and real-time PCR were performed as described
before [27]. Primers were: mouse β-Actin: 5′-AGC CAT
GTA CGT AGC CAT CC-3′ and 5′-CTC TCA GCT
GTG GTG GTG AA-3′, mouse Lysozyme M: 5′-CTG
GCT ACT ATG GAG TCA GC-3′and 5′-TTG ATC CCA
CAG GCA TTC AC-3′, mouse MIP-2: 5′-AAG TTT
GCC TTG ACC CTG AA-3′ and 5′-AGG CAC ATC
AGG TAC GAT CC-3′, and mouse mBD-1: 5′-GGC TGC
CAC CAC TAT GAA AAC TC-3′ and 5′-GAG ACA
GAATCC TCC ATG TTG AA-3′.
Statistical analysis
Values are displayed as mean ± SEM. The Mann–Whitney
test was used to compare the groups. Results were consid-
ered statistically significant for p < 0.05. All statistical tests
were performed using the software Prism (GraphPad
Software, San Diego, CA, USA).with NTHi. (A) Mice were exposed to CS or air as indicated and
y quantitative cultures of upper airway lavages 24 hours
ifferences of *p < 0.05, n≥ 5 per group. (B) NTHi are shown in nasal
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CS exposure promotes colonization of the upper airways
with NTHi and S. pneumoniae
To investigate whether exposure to CS enhances initial
nasopharyngeal colonization, mice were chronically
exposed to CS or room air for 3 or 7 months before
intranasal inoculation with a nontypeable patient
isolate of H. influenzae (NTHi) or an S. pneumoniae
6A strain, using a physiologically relevant and well-
characterized murine model of colonization of the
upper airways [22-24,28]. In this colonization model,
stable colonization of S. pneumoniae occurs at the
epithelial surfaces of the upper airways over period
of 14 days before bacteria are cleared by cellular ef-
fectors, whereas NTHi are efficiently cleared within
24 hours [22-24,29]. Thus, we examined the effect of CS
on initial nasopharyngeal colonization of S. pneumoniae
4 and 7 days post-inoculation and on nasopharyngeal
colonization of NTHi 24 hours post-inoculation. In
line with the literature, only marginal numbers of vi-
able NTHi were determined in upper airway lavages of
air-exposed mice 24 hours post-inoculation, whereas
S. pneumoniae efficiently colonized the upper airways
of air-exposed mice over a period of 7 days (Figures 1A
and 2A). Chronic exposure to CS for 3, respectivelyFigure 2 Colonization levels in the upper airways of mice inoculated
and intranasally inoculated with S. pneumoniae (S.p.). Colonization densities
4 days (3 months CS) and 7 days (7 months CS) postinoculation. (B) Numb
indicate significant differences of *p < 0.05 and **p < 0.01, n≥ 5 per group7 months, resulted in significantly increased colonization
levels in the upper airways of mice inoculated with NTHi
or S. pneumoniae, as compared to those exposed to air
(Figures 1A and 2A). Colonization densities of NTHi
were three magnitudes greater in the upper airways of
mice exposed to CS for 3 and 7 months 24 hours after in-
oculation, as compared to corresponding air-exposed
mice (Figure 1A). Figure 1B shows NTHi in the upper re-
spiratory tract of room air- and CS-exposed mice on
nasal sections. Moreover, in the case of inoculation with
S. pneumoniae, colonization densities in the upper air-
ways were 5 times higher in mice exposed to CS for
3 months and 2 times higher in mice exposed to CS
for 7 months, 4, respectively 7, days after inoculation
(Figure 2A).
CS exposure leads to increased translocation of
S. pneumoniae into the lung
We examined whether increased colonization of the
upper airways correlated with enhanced bacterial num-
bers in the lung. To determine the number of viable bac-
teria in lung tissue, the lungs were dissected and the
trachea was removed. CFUs were determined in lung
homogenates. Viable NTHi were not detectable in the
lung tissue of either CS- or air-exposed mice. Only smallwith S. pneumoniae. (A) Mice were exposed to CS or air as indicated
were determined by quantitative cultures of upper airway lavages
ers of viable S.p. were determined in lung tissue (homogenate). Bars
.
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in the lung tissue of both air- and CS-exposed mice
(Figure 2B). The numbers of S. pneumoniae in the lung
tissue were, however, enhanced in mice which had been
chronically exposed to CS prior to bacterial colonization.
Significantly increased numbers of viable S. pneumoniae
were determined in the lung tissue of mice exposed to
CS for 3 months, as compared to corresponding air-
exposed mice 4 days after inoculation (Figure 2B).Figure 3 Concentrations of inflammatory mediators in upper airway l
NTHi or S. pneumoniae. Mice were exposed to CS or air for 3 months and i
of KC (A), RANTES (B), and IL-6 (C) were measured in upper airway lavages of
shown as mean ± SEM. Bars indicate significant differences of *p < 0.05 and **CS exposure increases the expression of inflammatory
cytokines in the upper airways of mice colonized
with NTHi
We further examined whether chronic exposure to
CS exacerbates upper airway inflammation induced
by colonizing bacteria. Figure 3 shows that concen-
trations of inflammatory mediators were increased in
upper airway lavages of mice chronically exposed to
CS and colonized with NTHi or S. pneumoniae, asavages of mice chronically exposed to CS and colonized with
ntranasally inoculated with NTHi or S. pneumoniae (S.p.). Concentrations
mice by CBA 24 hours (NTHi) and 4 days (S.p.) postinoculation. Data are
p < 0.01, n≥ 5 per group.
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tions of KC, a major murine chemoattractant for
neutrophils, were significantly increased in upper air-
way lavages of mice exposed to CS and colonized
with NTHi, as compared to air-exposed mice colo-
nized with NTHi and non-infected mice (Figure 3A).
CS exposure and colonization with NTHi alone did
not result in significantly increased concentrations of
KC as compared to air-exposed control mice. Expos-
ure to CS slightly - however not significantly (p = 0.072) -
increased concentrations of KC in upper airway lavages
of mice colonized with S. pneumoniae (Figure 3A).
Similar to KC, concentrations of RANTES (also named
CCL5), a major chemoattractant for monocytes, were
significantly increased in upper airway lavages of mice
exposed to CS and colonized with NTHi, as compared
to air-exposed mice colonized with NTHi and non-
infected mice (Figure 3B). However, exposure to CS
alone also led to significantly increased concentrations
of RANTES in upper airway lavages, as compared to
non-infected control mice, whereas colonization of air-
exposed mice with NTHi or S. pneumoniae did not lead
to increased concentrations of RANTES. Colonization of
air-exposed mice with NTHi or S. pneumonaie led to in-
creased concentrations of IL-6 in upper airway lavages,
which was not further increased in animals exposed to
CS (Figure 3C). We further examined the expression of
lysozyme, the antimicrobial peptide mBD-1 and the che-
mokine MMP-2 by qRT-PCR with RNA obtained from
the upper airways of mice colonized with NTHi. It has
been shown before that mBD-1 deficient mice are more
susceptible to H. influenzae lung infection [30]. Chronic
exposure to CS suppressed the expression of the anti-
microbial peptide mBD-1 and increased the expression of
the chemokine MIP-2 whereas the expression of lyso-
zyme was not affected by CS (Figure 4).Figure 4 Expression of inflammatory mediators in the upper respiratory
inoculated with NTHi. Total RNA was obtained by flushing the upper airways
(C) was determined by qRT-PCR. Data are shown as mean ± SEM. n = 4 per grCS exposure does not inhibit the recruitment of
inflammatory cells in the upper airways of colonized mice
We determined the total numbers of inflammatory cells
in upper airway lavages and differentiated macrophages
and neutrophils on cytospins. Exposure to CS and
bacterial colonization led to a significantly increased
influx of total immune cells (Figure 5A), neutrophils
(Figure 5B), and macrophages (Figure 5C) into the upper
airways. The number of neutrophils in upper airway
lavages was approximately one magnitude higher than the
number of macrophages. Numbers of total immune cells,
neutrophils, and macrophages were significantly increased
in upper airway lavages of mice exposed to CS and colo-
nized with NTHi, as compared to non-infected air- and
CS-exposed mice (Figure 5). The number of total immune
cells, neutrophils, and macrophages was increased in
upper airway lavages of CS-exposed NTHi-colonized mice
compared to those of air-exposed NTHi-colonized
mice. However, the differences did not reach statistical
significance.
The phagocytosis activity is reduced in whole blood
granulocytes and monocytes
Having shown that the influx of immune cells into the
upper airways of colonized mice is not inhibited by CS,
we determined whether the phagocytosis activity of
granulocytes and monocytes was affected by exposure to
CS. As there are only marginal numbers of granulocytes
and monocytes present in the upper airways of non-
colonized animals, we determined the ability of granulo-
cytes and monocytes obtained from anticoagulated
whole blood to phagocytose FITC-conjugated Escheri-
chia coli. The phagocytosis activity was reduced in
granulocytes and monocytes of mice exposed to CS for
3 months compared to those of air-exposed mice
(Figure 6).tract. Mice were exposed to CS or air for 7 months and intranasally
with lysis buffer. The expression of mBD-1 (A), lysozyme (B) and MIP-2
oup.
Figure 5 Influx of inflammatory cells in the upper airways. Mice were exposed to CS or air for 3 months and intranasally inoculated with
NTHi or S. pneumoniae (S.p.). Numbers of total immune cells (A), neutrophils (B) and macrophages (C) were determined in upper airway lavages
24 hours (NTHi) and 4 days (S.p.) postinoculation. Data are shown as mean ± SEM. Bars indicate significant differences of *p < 0.05 and **p < 0.01,
n≥ 5 per group.
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recruitment of immune cells into the lung
To examine whether chronic exposure to CS and bacter-
ial colonization affects recruitment of immune cells into
the lung we determined the total number of immune
cells, macrophages, and neutrophils in bronchoalveolar
lavage (BAL) fluids. The total number of immune cells
and macrophages was significantly increased in BALfluids of CS-exposed mice and there was an increase in
macrophages in colonized air-exposed mice, as com-
pared to air-exposed control mice (Figure 7A and B).
Interestingly, there was a significant increase in the
number of total immune cells and macrophages in mice
chronically exposed to CS and colonized with NTHi or
S. pneumoniae, as compared to CS-exposed control mice
and colonized air-exposed mice (Figure 7A and B). In
Figure 6 Effect of CS on E. coli-induced phagocytosis. Whole
blood samples were obtained from mice exposed to CS or air for
3 months and incubated with FITC-conjugated E. coli. Phagocytosis
activity is shown as mean fluorescence intensity (MFI). Data are
shown as mean ± SEM. Bars indicate significant differences of
**p < 0.01, n = 3 per group in duplicates.
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CS-exposed mice ex vivo with NTHi or S. pneumoniae
for 4 hours. There was no difference between the release
of KC in alveolar macrophages obtained from CS-
exposed mice and those of air-exposed mice after bacter-
ial stimulation (data not shown).
Discussion
We combined a murine model of colonization of
the upper respiratory tract with a model of COPD to in-
vestigate whether CS-induced inflammation promotes
acquisition of bacterial lung pathogens and whether col-
onizing of the upper airways contributes to increased
inflammation in the respiratory tract. We focused on
NTHi as this bacterium frequently colonizes lungs of
COPD patients and is linked to exacerbations of COPD
[2,5] and on S. pneumoniae as colonization of the nasal
space by pneumococci occasionally causes pneumonia
and invasive disease, especially in subjects exposed to CS
or passive smoke [17-19]. Our data show that chronic
exposure to CS has an impact on the ability of the host
to contain bacterial colonization of the upper airways
with bacterial pathogens and that CS-induced colonization
is accompanied by increased inflammation of the respira-
tory tract and susceptibility of the host to pathogens
migrating into the lung.
It is hypothesized that exacerbations in COPD are pro-
voked by bacterial strains newly acquired from the envir-
onment [2,3]. In line with this hypothesis, our study
proves that COPD-like inflammation promotes theacquisition of typical COPD pathogens, such as NTHi,
into the upper airways. Increased colonization of the
upper airways of CS-exposed mice with NTHi is also
associated with an enhanced inflammation in the respira-
tory tract characterized by an increased release of chemo-
kines and influx of immune cells into the upper airways
and into the lung. Thus, our data suggest that CS promotes
the acquisition and colonization of the upper airways with
respiratory pathogens and that these newly- acquired path-
ogens contribute to the progression of COPD by enhan-
cing and perpetuating lung inflammation [2,3,8].
For many bacterial pathogens colonization of the
upper airways is often a first step in the process leading
to infectious diseases [22,23]. Frequent acquisition of
bacterial pathogens in the upper airways may also pro-
mote infectious lung diseases and invasive diseases in
individuals exposed to mainstream or passive smoke.
Our data indicate that the increased risk of smokers for
community-acquired pneumonia and invasive pneumo-
coccal disease [17-19] and the increased risk of infants
exposed to passive smoke of developing infections of the
lower respiratory tract [20] are a direct consequence of
CS-induced acquisition of bacterial pathogens into the
upper airways. Our results are further in line with find-
ings that children of smoking parents have a significantly
higher rate of S. pneumoniae carriage than those of non-
smokers [14].
Several studies have examined how CS affects immune
mechanisms at the mucosal surfaces of the respiratory
tract [9,27,31-36]. In vitro studies have shown that ex-
posure of respiratory epithelial cells to CS results in the
suppression of cellular signaling cascades (e.g. AP-1- and
NF-κB-dependent signaling cascades) that are of key
importance in the activation of innate immune mecha-
nisms in the case of microbial infections [31,35,36].
Thus, in vitro, CS exposure results in a reduced expres-
sion and release of inflammatory mediators and anti-
microbial peptides by respiratory epithelial cells infected
with bacterial pathogens [9,27,31,35,36]. Moreover, we
have previously shown that smokers with community-
acquired pneumonia have reduced levels of antimicrobial
peptides in their sputum and pharyngeal washings [9].
In this study, we found that chronic CS exposure re-
sulted in reduced expression levels of the antimicrobial
peptide mBD-1 in the upper airways of NTHi-colonized
mice, even though the colonization levels were increased
in CS-exposed mice, as compared to air-exposed mice.
It has been shown before that mBD-1 deficient mice are
more susceptible to H. influenzae lung infection [30].
Furthermore, it has been shown that CS increases
adhesion of bacteria to epithelial cells [37-40]. Grigg
et al. showed, for instance, that CS extract stimulates
platelet-activating factor receptor- dependent adhesion of
S. pneumonaie to respiratory epithelial cells [39]. Thus,
Figure 7 Influx of inflammatory cells in the lung. Mice were exposed to CS or air for 3 months and intranasally inoculated with NTHi or
S. pneumoniae (S.p.). Numbers of total immune cells (A), macrophages (B) and neutrophils (C) were determined in BAL fluids 24 hours (NTHi) and
4 days (S.p.) postinoculation. Bars indicate significant differences of *p < 0.05 and **p < 0.01, n ≥ 5 per group.
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epithelial cells, including the expression of epithelial anti-
microbial peptides as well as increased bacterial adherence
to epithelial cells, are potential mechanisms responsible
for the increased levels of colonization observed in mice
chronically exposed to CS.Studies have also shown that CS impairs the response
of immune cells such as alveolar macrophages and neu-
trophils to bacterial pathogens, which results in a
deregulated release of inflammatory mediators and im-
paired phagocytic activity [41-44]. Alveolar macrophages
from ex-smokers with COPD, for instance, showed a
Voss et al. Respiratory Research  (2015) 16:41 Page 10 of 11reduced expression of inflammatory mediators (e.g.
TNF-α) in response to antigens of H. influaenzae, com-
pared to macrophages obtained from ex-smokers with-
out COPD and non-smokers [41]. Moreover, ex vivo
studies with alveolar macrophages obtained from CS-
exposed mice showed that CS exposure enhances the
release of the chemokines IL-1α and MCP-1 and in-
hibits the release of TNF-α by alveolar macrophages
stimulated with NTHi [42,43]. Berenson et al. showed
that the phagocytosis of NTHi is impaired in alveolar
macrophages obtained from donors with COPD, as
compared to that from donors without COPD [45].
Taylor et al. found that monocyte-derived macrophages
from COPD patients showed reduced phagocytic re-
sponses to H. influenza and S. pneumoniae, compared
with smokers and non-smokers, which was not ob-
served by Berenson et al. [46]. Exposure to CS extract
also resulted in a reduced uptake of NTHi by murine
and human cell line-derived macrophages [44]. Expos-
ure to CS extracts also reduced the complement-
mediated phagocytosis of S. pneumoniae by alveolar
macrophages ex vivo [33] and the phagocytosis of
E. coli by human neutrophils [34]. In our model,
chronic exposure to CS did not result in a defect in
the recruitment of phagocytes into the upper airways
in response to colonizing bacteria. Chronic CS exposure
resulted in increased numbers of neutrophil and macro-
phages in the upper airways of mice colonized with
NTHi and S. pneumoniae, which was associated with in-
creased levels of chemokines in upper airway lavages.
However, the phagocytosis activity of whole blood granu-
locytes and monocytes was inhibited in CS-exposed mice.
This was a surprising and not suspected finding which
might have impact on extra pulmonal research on to-
bacco smoke, too. Thus, it is conceivable that impaired
phagocytosis of NTHi and S. pneumoniae by neutrophils
and macrophages is another potential cause of the
increased colonization levels in the upper airways of
CS-exposed mice.
In summary, our data indicate that continuous ex-
posure to CS opens a niche for typical COPD patho-
gens in the upper airways, which results in the
acquisition of bacterial pathogens. Our data suggest
that bacterial pathogens efficiently colonizing the mu-
cosal surfaces of the upper respiratory tract contribute
to increased lung colonization and are a cause of pul-
monary inflammation. Frequent acquisition of bacterial
pathogens into the upper airways may also promote
pneumonia and invasive diseases in individuals ex-
posed to mainstream or passive smoke. Our model
system provides a tool for future mechanistic studies
to examine mechanisms and potential therapeutic in-
terventions regarding bacterial colonization and COPD
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